Importer of Controlled Substances Registration, 95647 [2016-31273]
Download as PDF
95647
Federal Register / Vol. 81, No. 249 / Wednesday, December 28, 2016 / Notices
Controlled substance
Drug code
Meperidine ...............................................................................................................................................................
Meperidine intermediate-B .......................................................................................................................................
Methadone ...............................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ......................................................................................................
Morphine ..................................................................................................................................................................
Thebaine ..................................................................................................................................................................
Oxymorphone ..........................................................................................................................................................
Alfentanil ..................................................................................................................................................................
Remifentanil .............................................................................................................................................................
Sufentanil .................................................................................................................................................................
Carfentanil ................................................................................................................................................................
Tapentadol ...............................................................................................................................................................
Fentanyl ...................................................................................................................................................................
The company plans to manufacture
bulk controlled substances for use in
product development of analytical
reference standards, for distribution to
its customers.
Drug Enforcement Administration
[Docket No. DEA–392]
SUPPLEMENTARY INFORMATION:
ACTION:
[FR Doc. 2016–31285 Filed 12–27–16; 8:45 am]
Notice of registration.
Registrants listed below have
applied for and been granted
registration by the Drug Enforcement
SUMMARY:
BILLING CODE 4410–09–P
Company
sradovich on DSK3GMQ082PROD with NOTICES
Rhodes Technologies ...........................................................
Bellwyck Clinical Services ....................................................
Cerilliant Corporation ............................................................
Noramco, Inc ........................................................................
Cody Laboratories, Inc .........................................................
AMRI Rensselaer, Inc ..........................................................
ALMAC Clinical Services Incorp (ACSI) ..............................
Fresenius Kabi USA, LLC ....................................................
Akorn, Inc .............................................................................
Actavis Laboratories FL, Inc ................................................
Unither Manufacturing LLC ..................................................
Cambrex Charles City ..........................................................
United States Pharmacopeial Convention ...........................
R & D Systems, Inc ..............................................................
Catalent CTS, LLC ...............................................................
VerDate Sep<11>2014
18:54 Dec 27, 2016
Jkt 241001
The companies listed below applied
to be registered as importers of various
basic classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
FR docket
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrants to import the
applicable basic classes of schedule I or
II controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated each company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
II.
II.
II.
II.
II.
II.
II.
II.
II.
II.
II.
II.
II.
Administration (DEA) as importers of
various classes of schedule I or II
controlled substances.
DEPARTMENT OF JUSTICE
Importer of Controlled Substances
Registration
Dated: December 20, 2016.
Louis J. Milione,
Assistant Administrator.
9230
9233
9250
9273
9300
9333
9652
9737
9739
9740
9743
9780
9801
Schedule
81
81
81
81
81
81
81
81
81
81
81
81
81
81
81
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
46956
54603
57933
57932
54602
54603
54602
54601
57935
54602
61250
63222
63220
64509
66081
Published
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
granted a registration as an importer for
schedule I or II controlled substances to
the above listed persons.
Dated: December 19, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2016–31273 Filed 12–27–16; 8:45 am]
July 19, 2016.
August 16, 2016.
August 24, 2016.
August 24, 2016.
August 16, 2016.
August 16, 2016.
August 16, 2016.
August 16, 2016.
August 24, 2016.
August 16, 2016.
September 6, 2016.
September 14, 2016.
September 14, 2016.
September 20, 2016.
September 26, 2016.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before February 27, 2017.
DATES:
Drug Enforcement Administration
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
[Docket No. DEA–392]
SUPPLEMENTARY INFORMATION:
ADDRESSES:
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Bulk Manufacturer of Controlled
Substances Application: Johnson
Matthey Inc.
ACTION:
PO 00000
Notice of application.
Frm 00093
Fmt 4703
Sfmt 4703
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
E:\FR\FM\28DEN1.SGM
28DEN1
Agencies
[Federal Register Volume 81, Number 249 (Wednesday, December 28, 2016)]
[Notices]
[Page 95647]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-31273]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Registrants listed below have applied for and been granted
registration by the Drug Enforcement Administration (DEA) as importers
of various classes of schedule I or II controlled substances.
SUPPLEMENTARY INFORMATION:
The companies listed below applied to be registered as importers of
various basic classes of controlled substances. Information on
previously published notices is listed in the table below. No comments
or objections were submitted and no requests for hearing were submitted
for these notices.
----------------------------------------------------------------------------------------------------------------
Company FR docket Published
----------------------------------------------------------------------------------------------------------------
Rhodes Technologies...................... 81 FR 46956................. July 19, 2016.
Bellwyck Clinical Services............... 81 FR 54603................. August 16, 2016.
Cerilliant Corporation................... 81 FR 57933................. August 24, 2016.
Noramco, Inc............................. 81 FR 57932................. August 24, 2016.
Cody Laboratories, Inc................... 81 FR 54602................. August 16, 2016.
AMRI Rensselaer, Inc..................... 81 FR 54603................. August 16, 2016.
ALMAC Clinical Services Incorp (ACSI).... 81 FR 54602................. August 16, 2016.
Fresenius Kabi USA, LLC.................. 81 FR 54601................. August 16, 2016.
Akorn, Inc............................... 81 FR 57935................. August 24, 2016.
Actavis Laboratories FL, Inc............. 81 FR 54602................. August 16, 2016.
Unither Manufacturing LLC................ 81 FR 61250................. September 6, 2016.
Cambrex Charles City..................... 81 FR 63222................. September 14, 2016.
United States Pharmacopeial Convention... 81 FR 63220................. September 14, 2016.
R & D Systems, Inc....................... 81 FR 64509................. September 20, 2016.
Catalent CTS, LLC........................ 81 FR 66081................. September 26, 2016.
----------------------------------------------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of the listed registrants
to import the applicable basic classes of schedule I or II controlled
substances is consistent with the public interest and with United
States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. The DEA investigated each company's
maintenance of effective controls against diversion by inspecting and
testing each company's physical security systems, verifying each
company's compliance with state and local laws, and reviewing each
company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer for schedule I or II controlled substances to the above
listed persons.
Dated: December 19, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2016-31273 Filed 12-27-16; 8:45 am]
BILLING CODE 4410-09-P